Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$191.17 - $325.63 $542,349 - $923,812
-2,837 Reduced 2.36%
117,561 $38.3 Million
Q4 2023

Feb 14, 2024

BUY
$160.99 - $215.69 $5.48 Million - $7.34 Million
34,025 Added 39.39%
120,398 $22.9 Million
Q3 2023

Nov 14, 2023

BUY
$194.33 - $283.97 $4.4 Million - $6.43 Million
22,635 Added 35.51%
86,373 $17.2 Million
Q2 2023

Aug 14, 2023

BUY
$223.05 - $302.68 $4 Million - $5.43 Million
17,939 Added 39.17%
63,738 $18.2 Million
Q1 2023

May 17, 2023

BUY
$175.41 - $217.92 $423,790 - $526,494
2,416 Added 5.57%
45,799 $9.93 Million
Q4 2022

Feb 08, 2023

BUY
$204.38 - $296.82 $864,118 - $1.25 Million
4,228 Added 10.8%
43,383 $8.92 Million
Q3 2022

Nov 14, 2022

BUY
$195.21 - $310.53 $5.81 Million - $9.24 Million
29,765 Added 316.99%
39,155 $10.9 Million
Q2 2022

Aug 16, 2022

BUY
$115.91 - $214.48 $1.09 Million - $2.01 Million
9,390 New
9,390 $1.8 Million

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.